Giuseppe Bruno

Author PubWeight™ 40.34‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation. Biol Psychiatry 2013 1.58
2 Increased levels of acute-phase inflammatory proteins in plasma of patients with sporadic CJD. Neurology 2012 1.49
3 Contribution of right hemisphere to visual imagery: a visual working memory impairment? J Int Neuropsychol Soc 2008 1.44
4 5-Arylidene-2-imino-4-thiazolidinones: design and synthesis of novel anti-inflammatory agents. Bioorg Med Chem 2005 1.29
5 Trinuclear heterobimetallic complexes with binucleating dithioxamides: stereoselective synthesis and solution behavior involving Pd-N bond rupture. Inorg Chem 2003 1.18
6 Exact distinction of excitatory and inhibitory neurons in neural networks: a study with GFP-GAD67 neurons optically and electrophysiologically recognized on multielectrode arrays. Front Neural Circuits 2012 1.18
7 The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings. J Alzheimers Dis 2013 0.98
8 catena-Poly[bis-(4-amino-pyridinium) [[tetra-aqua-nickel(II)]-μ-benzene-1,2,4,5-tetra-carboxyl-ato] dihydrate]. Acta Crystallogr Sect E Struct Rep Online 2009 0.97
9 N,N'-Dibenzyl-N,N'-dimethyl-N''-(methyl-sulfon-yl)phospho-ric triamide. Acta Crystallogr Sect E Struct Rep Online 2011 0.96
10 4-[(4-Chloro-phen-yl)diazen-yl]-3-meth-oxy-aniline. Acta Crystallogr Sect E Struct Rep Online 2011 0.95
11 Replication study to confirm the role of CYP2D6 polymorphism rs1080985 on donepezil efficacy in Alzheimer's disease patients. J Alzheimers Dis 2012 0.88
12 Allylpalladium dimers with metals connected by binucleating dithiooxamidates in two different coordination modes: solution behavior and solid-state structure. Inorg Chem 2011 0.88
13 Regio and diastereoselective lactonisation of enolisable 1,3-dicarbonyls by reaction with mesoionic 1,3-oxazolium-5-olates. Chem Commun (Camb) 2003 0.88
14 3-(2-Eth-oxy-phen-yl)-1-(3-nitro-phen-yl)triaz-1-ene. Acta Crystallogr Sect E Struct Rep Online 2011 0.88
15 N,N-Dimethyl-propane-1,2-diaminium bis-(6-carb-oxy-pyridine-2-carboxyl-ate) monohydrate. Acta Crystallogr Sect E Struct Rep Online 2011 0.88
16 2,3-Diamino-pyridinium 6-carb-oxy-pyridine-2-carboxyl-ate. Acta Crystallogr Sect E Struct Rep Online 2011 0.86
17 Chronic inflammation in a long-term cohort of HIV-infected patients according to the normalization of the CD4:CD8 ratio. AIDS Res Hum Retroviruses 2014 0.83
18 A novel mutation in the predicted TMIII domain of the PSEN2 gene in an Italian pedigree with atypical Alzheimer's disease. J Alzheimers Dis 2010 0.82
19 Limiting severe outcomes and impact on intensive care units of moderate-intermediate 2009 pandemic influenza: role of infectious diseases units. PLoS One 2012 0.82
20 Functional and structural characterization of ovine ornithine transcarbamoylase. Org Biomol Chem 2003 0.82
21 Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids. J Med Chem 2003 0.81
22 Behavioral and psychological subsyndromes in Alzheimer's disease using the Neuropsychiatric Inventory. Int J Geriatr Psychiatry 2012 0.81
23 Gender effects on plasma PGRN levels in patients with Alzheimer's disease: a preliminary study. J Alzheimers Dis 2013 0.80
24 X4 viruses are frequently archived in patients with long-term HIV infection but do not seem to influence the "inflamm-aging" process. BMC Infect Dis 2013 0.80
25 New Adducts of Dirhodium(II) Formamidinate Complexes with Polycyano Acceptor Molecules. X-ray Crystal Structure of the Tricyanomethanide Complex Rh(2)(form)(4)[C(CN)(3)] (form = N,N'-Di-p-tolylformamidinate). Inorg Chem 1997 0.79
26 Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitors. Neurobiol Aging 2013 0.79
27 Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study. J Neurol 2013 0.77
28 Rivastigmine in the treatment of hypersexuality in Alzheimer disease. Alzheimer Dis Assoc Disord 2013 0.77
29 Cessation versus continuation of galantamine treatment after 12 months of therapy in patients with Alzheimer's disease: a randomized, double blind, placebo controlled withdrawal trial. J Alzheimers Dis 2011 0.77
30 Position paper of the Italian Society for the study of Dementias (SINDEM) on the proposal of a new lexicon on Alzheimer disease. Neurol Sci 2011 0.77
31 Dithioether ligands containing a 2,6-disubstituted pyridine linker with two thioether-heterocycle arms. Acta Crystallogr C 2009 0.76
32 Cognitive interventions targeting subjective cognitive complaints. Am J Alzheimers Dis Other Demen 2013 0.76
33 A pilot study on the use of interferon beta-1a in early Alzheimer's disease subjects. J Neuroinflammation 2014 0.76
34 Diosmin binding to human serum albumin and its preventive action against degradation due to oxidative injuries. Biochimie 2013 0.76
35 (Dipyrido[3,2-a:2',3'-c]phenazine)(glycinato)copper(II) perchlorate: a novel DNA-intercalator with anti-proliferative activity against thyroid cancer cell lines. J Inorg Biochem 2012 0.76
36 1-[((E)-{2-[(2-Nitro-benz-yl)(2-{[(E)-(2-oxidonaphthalen-1-yl)methyl-idene]aza-nium-yl}eth-yl)amino]-eth-yl}aza-niumyl-idene)meth-yl]naphthalen-2-olate monohydrate. Acta Crystallogr Sect E Struct Rep Online 2011 0.75
37 N-(3-Fluoro-benzo-yl)-N',N''-bis-(4-methyl-phen-yl)phospho-ric triamide. Acta Crystallogr Sect E Struct Rep Online 2011 0.75
38 Chlorido(η-cyclo-octa-1,5-diene)(N,N'-diethyl-thio-urea-κS)rhodium(I). Acta Crystallogr Sect E Struct Rep Online 2010 0.75
39 N-(2-Eth-oxy-phen-yl)formamide. Acta Crystallogr Sect E Struct Rep Online 2012 0.75
40 Bis[1-(2-eth-oxy-phen-yl)-3-(4-nitro-phen-yl)triazenido]mercury(II). Acta Crystallogr Sect E Struct Rep Online 2010 0.75
41 Bis[2-(2-amino-ethyl-amino)-ethanol]copper(II) dinitrate. Acta Crystallogr Sect E Struct Rep Online 2011 0.75
42 [(Z)-1-({3-[(3-Amino-prop-yl)(2-nitro-benz-yl)amino]-prop-yl}imino-meth-yl)naphthalen-2-olato]copper(II) perchlorate. Acta Crystallogr Sect E Struct Rep Online 2011 0.75
43 A functionalized enol lactone containing a protected α-amino acid. Acta Crystallogr Sect E Struct Rep Online 2010 0.75
44 Diphenyl (cyclo-pentyl-amido)-phospho-nate. Acta Crystallogr Sect E Struct Rep Online 2011 0.75
45 Tetra-kis(μ-4-chloro-benzoato-κ(2) O:O')bis-[(ethanol-κO)copper(II)](Cu-Cu). Acta Crystallogr Sect E Struct Rep Online 2013 0.75
46 Methyl 2-{2-[(E)-(2-hy-droxy-3-meth-oxy-benzyl-idene)amino]-ethyl-amino}-cyclo-pentene-1-carbodithio-ate. Acta Crystallogr Sect E Struct Rep Online 2011 0.75
47 N,N'-Dicyclo-hexyl-N''-(3-fluoro-benzo-yl)-N,N'-dimethyl-phospho-ric triamide. Acta Crystallogr Sect E Struct Rep Online 2011 0.75
48 (S)-2-[(2-Hy-droxy-benz-yl)aza-nium-yl]-4-(methyl-sulfan-yl)butano-ate. Acta Crystallogr Sect E Struct Rep Online 2011 0.75
49 3-(4-Bromo-anilino)-3-(4-chloro-phen-yl)-1-phenyl-propan-1-one. Acta Crystallogr Sect E Struct Rep Online 2011 0.75
50 Propane-1,2-diaminium bis-(pyridine-2,6-dicarboxyl-ato-κO,N,O)mercurate(II) dihydrate. Acta Crystallogr Sect E Struct Rep Online 2011 0.75
51 catena-Poly[[[μ-aqua-penta-aqua-dizinc(II)]-μ(4)-benzene-1,2,4,5-tetra-carboxyl-ato] dihydrate]. Acta Crystallogr Sect E Struct Rep Online 2009 0.75
52 Synthesis, resolution, stereochemistry, and molecular modeling of (R)- and (S)-2-acetyl-1-(4'-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline AMPAR antagonists. Bioorg Med Chem 2007 0.75
53 A new tridentate Schiff base Cu(II) complex: synthesis, experimental and theoretical studies on its crystal structure, FT-IR and UV-Visible spectra. Spectrochim Acta A Mol Biomol Spectrosc 2013 0.75
54 Presenilin 2 mutation R71W in an Italian early-onset sporadic Alzheimer's disease case. J Neurol 2011 0.75
55 Effect of chelating vs. bridging coordination of chiral short-bite P-X-P (X=C, N, O) ligands in enantioselective palladium-catalysed allylic substitution reactions. Dalton Trans 2003 0.75
56 The absolute configuration of palladium(II) and ruthenium(II) pseudochiral centers in either chiral or achiral environments. Inorg Chem 2010 0.75
57 [Use of neuropsychological tests in the Cronos Project]. Ann Ist Super Sanita 2005 0.75
58 Origin of enantioselectivity in palladium-catalyzed asymmetric allylic alkylation reactions using chiral N,N-ligands with different rigidity and flexibility. Dalton Trans 2007 0.75
59 Effect of citalopram in treating hypersexuality in an Alzheimer's disease case. Neurol Sci 2008 0.75
60 Charge injection into nanostructured TiO2 electrodes from the photogenerated reduced form of a new Ru(ii) polypyridine compound: the "anti-biomimetic" mechanism at work. Dalton Trans 2016 0.75
61 Enantioseparation, absolute configuration determination, and anticonvulsant activity of (+/-)-1-(4-aminophenyl)-7,8-methylenedioxy-1,2,3,5-tetrahydro-4H-2,3-benzodiazepin-4-one. Chirality 2007 0.75
62 Synthesis and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-D-aspartate receptors. J Med Chem 2011 0.75
63 [Evidence-based prevention: a new model for public health]. Ig Sanita Pubbl 2007 0.75
64 Three new [XC(O)NH]P(O)[N(CH2C6H5)2]2 phosphoric triamides (X = CClF2, 3-F-C6H4 and 3,5-F2-C6H3): a database analysis of tertiary N-atom geometry in compounds with a C(O)NHP(O)[N]2 core. Acta Crystallogr C 2012 0.75
65 Predicting the Rate of Cognitive Decline in Alzheimer Disease: Data From the ICTUS Study. Alzheimer Dis Assoc Disord 2016 0.75